Hypofractionated, Reduced Margin, Intensity Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Patients with Glioblastoma Multiforme: A Pattern of Failure Analysis

被引：0
|
作者：
Shakibnia, L. [1 ]
Roberge, D. [1 ]
Souhami, L. [1 ]
Lambert, C. [1 ]
Raymond, V. Panet [1 ]
Shenouda, G. [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 50 条
  • [41] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Michelle Alonso-Basanta
    Penny Fang
    Amit Maity
    Stephen M. Hahn
    Robert A. Lustig
    Jay F. Dorsey
    Journal of Neuro-Oncology, 2014, 116 : 365 - 372
  • [42] Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma
    Kevin Petrecca
    Marie-Christine Guiot
    Valerie Panet-Raymond
    Luis Souhami
    Journal of Neuro-Oncology, 2013, 111 : 19 - 23
  • [43] Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma
    Petrecca, Kevin
    Guiot, Marie-Christine
    Panet-Raymond, Valerie
    Souhami, Luis
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (01) : 19 - 23
  • [44] Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience
    Cao, Jeffrey Q.
    Fisher, Barbara J.
    Bauman, Glenn S.
    Megyesi, Joseph F.
    Watling, Christopher J.
    Macdonald, David R.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (02) : 395 - 405
  • [45] Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience
    Jeffrey Q. Cao
    Barbara J. Fisher
    Glenn S. Bauman
    Joseph F. Megyesi
    Christopher J. Watling
    David R. Macdonald
    Journal of Neuro-Oncology, 2012, 107 : 395 - 405
  • [46] Hypofractionated radiotherapy with concurrent temozolomide chemotherapy in patients with newly diagnosed RPA class V glioblastoma multiforme: promising early results
    Ye, Jason C.
    Yondorf, Menachem
    Pannullo, Susan C.
    Boockvar, John A.
    Stieg, Philip E.
    Schwartz, Theodore H.
    Scheff, Ronald J.
    Parashar, Bhupesh
    Nori, Dattatreyudu
    Chao, K. S. Clifford
    Wernicke, A. Gabriella
    JOURNAL OF RADIATION ONCOLOGY, 2015, 4 (01) : 19 - 27
  • [47] Phase 2 Trial of Hypofractionated High-Dose Intensity Modulated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
    Iuchi, Toshihiko
    Hatano, Kazuo
    Kodama, Takashi
    Sakaida, Tsukasa
    Yokoi, Sana
    Kawasaki, Koichiro
    Hasegawa, Yuzo
    Hara, Ryusuke
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (04): : 793 - 800
  • [48] FEASIBILITY AND SURVIVAL BENEFIT OF HYPOFRACTIONATED RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE AND BEVACIZUMAB IN ELDERLY PATIENTS WITH GLIOBLASTOMA
    Mitobe, Y.
    Matsuda, K.
    Sakurada, K.
    Sonoda, Y.
    NEURO-ONCOLOGY, 2017, 19 : 77 - 77
  • [49] Concurrent hypofractionated intensity-modulated radiation therapy with simultaneous integrated boost technique and temozolomide for glioblastoma
    Kim, J. H.
    Shin, S. S.
    Song, S. Y.
    Yang, S-H.
    Choi, E. K.
    Ahn, S. D.
    Lee, S-W.
    Kim, J. H.
    Kim, J. H.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S292 - S292
  • [50] Concurrent Radiotherapy and Temozolomide Followed by Temozolomide and Sorafenib in the First-Line Treatment of Patients With Glioblastoma Multiforme
    Hainsworth, John D.
    Ervin, Thomas
    Friedman, Elke
    Priego, Victor
    Murphy, Patrick B.
    Clark, Bobby L.
    Lamar, Ruth E.
    CANCER, 2010, 116 (15) : 3663 - 3669
12345